| More on the Baxter effort to buy Gambro. |
|
| Seeking alpha: If the rumour mill is to be trusted, Baxter International (BAX) is on the verge of buying the private Swedish dialysis company Gambro for a cool $4bn, and, while one should not believe everything in the papers, it does look like a very good purchase for the Chicago-based company. |